key: cord-0820164-aepg94jx authors: Kirsch, Brittany; Aziz, Moez; Kumar, Sungita; Burke, Michael; Webster, Tyler; Immadi, Amrutha; Sam, Maurine; Lal, Aditya; Estrada-Y-Martin, Rosa M; Cherian, Sujith; Aisenberg, Gabriel Marcelo title: WELLS SCORE TO PREDICT PULMONARY EMBOLISM IN PATIENTS WITH CORONAVIRUS DISEASE-2019 date: 2020-12-11 journal: Am J Med DOI: 10.1016/j.amjmed.2020.10.044 sha: 6a324073329070a623083415d26a2223732d6a2d doc_id: 820164 cord_uid: aepg94jx BACKGROUND: The association of Coronavirus Disease 2019 (COVID-19) with hypercoagulability has been extensively described. Consequently, pulmonary embolism is a recognized complication of COVID-19. Currently, the need for Computed Tomography Pulmonary Angiogram (CTPA) relies on the Wells score and serum D-dimer levels. However, since COVID-19 patients have a different thrombotic and inflammatory milieu, the usefulness of the Wells score deserves further exploration for this patient population. We aimed to explore the ability of the Wells score to predict pulmonary embolism in patients with COVID-19. METHODS: In this retrospective study, patients found to have a CTPA and a COVID-19 diagnosis during the same admission were selected for analysis. Patients’ age and gender, CTPA results, and associated D-dimer levels were entered in a database. The Wells score sensitivity and specificity were calculated at different values, and an area under the curve of a receiver operating characteristic curve (AUC/ROC) measured. RESULTS: Of 459 patients with COVID-19, 64 had a CTPA and 12 (19%) had evidence of pulmonary embolism. Previous or current evidence of deep vein thrombosis, a Wells score above four points, and serum D-dimer levels five times above age-adjusted upper normal values were associated with pulmonary embolism. However, only 33% of patients with PE had a Wells score of four points or higher. The AUC/ROC showed non-discriminating values (0.54) CONCLUSION: While a Wells score of four or more points predicted pulmonary embolism in our cohort, the outcome can be present even with lower scores. The Coronavirus Disease 2019 (COVID-19), first recognized in Wuhan, China, was declared a pandemic and has presented with heterogeneous signs and symptoms in more than 10 million people worldwide. 1 The association of COVID-19 with hypercoagulability manifested as arterial and venous thrombosis has been extensively described. Consequently, deep vein thromboses (DVT) and pulmonary embolism (PE) are recognized complications of COVID-19; in fact, elevated D-dimer levels have been considered markers of increased mortality among these patients. Also, there is ongoing discussion regarding the benefit of treating these patients with anticoagulation and/or thrombolytics. 2,3 The Wells score, a multi-point rule has been used to predict PE in the general population since 1997. 4, 5 Currently, the need for Computed Tomography Pulmonary Angiogram (CTPA) relies on the Wells score together with serum D-dimer levels. 5 However, since COVID-19 patients have a different thrombotic and inflammatory milieu, the usefulness of the Wells score deserves further exploration for this patient population and is addressed in this manuscript. The study was approved by the University of Texas at Houston IRB committee (HSC-MS-20-0542). A written informed consent for this study was waived. In this single center retrospective study, the electronic records of patients older than 17 years of age confirmed to have COVID-19, admitted between February 1st and July 15 th , 2020 to Lyndon B. Johnson Hospital (LBJH) in Houston, Texas were reviewed. Patients found to have a CTPA and a COVID-19 diagnosis during the same admission were selected for analysis. Patients' age and gender, CTPA results, and associated D-dimer levels were entered in a database. The Wells score was calculated for each of these patients. For patients older than 50 years, age-adjusted D-dimer levels were used to define the expected normal value as per current guidelines. 5 For the patients with or without CTPA who died, we evaluated whether they had an autopsy and reported whether evidence for PE or infarction was noted (Figure 1 ). MedCalc® version 12.3.0 (MedCalc Software; Mariakerke, Belgium) was used for the statistical analysis. Categorical variables were analyzed using the Fisher exact test and discrete variables were analyzed with use of the Student t-test for unpaired samples. A two-sided p < 0.05 was considered statistically significant. Sensitivity and specificity of the Wells score were assessed for Wells score cutoffs of one to six and a receiver operating characteristic (ROC) curve was generated. The area under this ROC curve (AUC) was calculated, and the location of shortest distance to 100% specificity and 100% sensitivity on the ROC curve was determined to delineate the optimal Wells cutoff score. Between February 1st and June 30th, 2020, 459 patients with COVID-19 were treated at Lyndon B Johnson Hospital (LBJH). Of those, 64 (13%) had a CTPA performed during the emergency department or hospital visit. The median age of the 64 patients was 55 ± 16 years. Thirty-five (55%) were men. Twelve of these patients (19%) had radiologic evidence of PE (10 segmental and 7 subsegmental, with some overlapped). The median Wells score for the cohort was 2 ± 2 (range 0-10.5). The characteristics of patients with and without PE on CTPA were compared ( Table 1 ). The AUC/ROC for an optimal value of Wells score between 1 and 2 was 0.54, suggesting virtual no-discrimination. One patient without a CTPA died fourteen days after admission and had evidence of subsegmental PE in the autopsy. One patient had autopsy evidence of subsegmental microinfarctions despite a negative CTPA ten days earlier. In our cohort, the radiologic incidence of PE was 19%. Current and prior evidence of DVT and serum D-dimer levels 5 times or more above the age-adjusted expected normal value predicted PE. The Wells score was significantly higher in the group with PE; however, four of the 12 patients with PE had a score of 0 points. The score value commonly recommended to evaluate for PE (>4) was more common among our patients with PE than those without. The subjective component of the Wells score "is PE the most likely diagnosis" was not a good predictor in our series. As a rule of thumb, clinicians will answer yes to that question when the chest X-radiograph is normal and the patient has other elements suggestive of PE, such as tachycardia and hypoxemia. Most patients admitted with COVID-19 have striking radiological abnormalities assumed to be the cause of such presentations. Moreover, this question, when positive, adds 3 points to the final score and has been criticized as being subjective and dependent on the accrual of points from other categories. 6 Finally, the Wells score altogether has been questioned regarding its ability to accurately predict PE in critically ill patients; consistent with this notion, in our cohort, the AUC/ROC showed non-discriminatory values. 7 Not surprisingly, the higher the serum D-dimer level, the more likely PE was observed. However, this may represent selection bias, since -though not always documented in the records-elevated serum D-dimer may have been the reason to order the CTPA. Serum D-dimer elevation has been previously documented as a marker of severity, even predicting mortality in patients with COVID-19. 8, 9 Only the patients deemed by doctors as needing a CTPA (13% of those with were entered in the analysis. While this fact limits our knowledge of how the Wells score would have performed in the remainder 87%, the AUC/ROC supports our overall findings. In conclusion, in our cohort, a Wells score above 4 was significantly associated with PE but the sensitivity and specificity of the score were unreliable. Serum D-dimer elevation also predicted PE, but in the setting of COVID-19 this feature may represent the severity of disease, regardless of the existence of demonstrable thrombosis. COMPETING INTERESTS: transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). A review The hypercoagulable state in COVID-19: incidence, pathophysiology, and management COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. JACC State-of-the-art review Value of assessment of pretest probability of deep-vein thrombosis in clinical management Management of pulmonary embolism. An update The physician's estimation 'alternative diagnosis is less likely than pulmonary embolism' in the Wells rule is dependent on the presence of other required items Wells and Geneva Scores are not reliable predictors of pulmonary embolism in critically ill patients: a retrospective study D-dimer is associated with severity of coronavirus disease 2019: A pooled analysis D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19 Figure 1. Distribution of patients with COVID-19 at LBJ Hospital The authors have no conflict of interest to disclose. This retrospective study was unfunded.Authorship role:BK and GMA conceived of the study.